Goethe University Frankfurt — Sponsor Intelligence | 14 EU Trials

Filter these 14 trials by condition, phase, country and more.

Open in Search →

14 Registered trials

5 Recruiting

7 Completed trials

2 Countries active

34 Unique IMPs

100% Results reported

Phase III

Phase II

Phase III: 3 Phase II: 9 Phase I/II: 1 Phase I (Other): 1

Oversight events:

2 temporary halts across 2 trials

View oversight register →

100%

7 of 7 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Anal cancer stage II 1 Rectal cancer 1 COVID-19 1 Anal cancer stage III 1

Top IMPs

BLINATUMOMAB 2 INTESTIFIX 2 ASCORBIC ACID, SODIUM ASCORBATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, SODIUM SULFATE ANHYDROUS, MACROGOL 3350 1 BUPROPION HYDROCHLORIDE 1 CALCIUM FOLINATE PENTAHYDRATE 1 CAPECITABINE 1 COLCHICINE 1 DURVALUMAB 1 FLUOROURACIL 1 FOSFOMYCIN TROMETAMOL 1 ISATUXIMAB 1 LOSARTAN POTASSIUM 1

All trials

14 total

Randomized, controlled, double-blind trial to investigate the effect of colchicin on the endothelial function in patients with CHIP mutation… Pending

2024-518383-12-00 Phase II 1 country COLCHICINE
The RAPID-Elapse study: Can the drug bupropion improve fatigue symptoms in patients with long COVID? Pending

2025-524443-12-00 Phase II 1 country BUPROPION HYDROCHLORIDE
Fecal microbiota transfer for the secondary prevention of recurrent urinary tract infections in premenopausal women: a phase II trial (FEMIT… Recruiting

2025-520452-28-00 Phase II 1 country ASCORBIC ACID, SODIUM ASCORBATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, SODIUM SUL…
A Randomized controlled open-label phase II trial assessing the efficacy and safety of two-dosing regimens of frozen encapsulated fecal micr… Recruiting

2024-519748-34-00 Phase II 1 country INTESTIFIX
A multicenter, single-arm phase II study to assess the safety, tolerability, and efficacy of Isatuximab in adult patients with cytologic or … Recruiting

2023-507899-47-00 Phase II 1 country ISATUXIMAB
A multicentre, randomized trial in adults with de novo Philadelphia-Chromosome positive acute lymphoblastic leukemia to assess the efficacy … Recruiting

2024-517966-40-00 Phase II 1 country BLINATUMOMAB; PONATINIB
Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblast… Recruiting

2024-511988-29-01 Phase I (Other) 1 country
An open label, phase I/II study of Venetoclax in addition to Blinatumomab immunotherapy in adult patients with relapsed/refractory B cell pr… Ended

2024-517959-12-00 Phase I/II 1 country BLINATUMOMAB; VENETOCLAX
Additional chemotherapy for EGFRm patients with the continued presence of plasma ctDNA EGFRm at week 3 after start of osimertinib 1st-line t… Ended

2024-517965-18-00 Phase II 1 country OSIMERTINIB
Short course radiotherapy versus chemoradiotherapy, followed by consolidation chemotherapy, and selective organ preservation for MRI-defined… Ended

2024-511577-29-01 Phase III 1 country CALCIUM FOLINATE PENTAHYDRATE; CAPECITABINE; FLUOROURACIL; OXALIPLATIN
RADIANCE Radiochemotherapy +/- Durvalumab for locally-advanced Anal Carcinoma A multicenter, randomized, phase II trial of the German Anal C… Ended

2024-513914-36-00 Phase II 2 countries DURVALUMAB
Randomized adaptive assessment of post COVID syndrome treatments (RAPID) Reducing Inflammatory Activity in Patients with post COVID Syndrome… Ended

2024-511628-16-00 Phase II 1 country VIDOFLUDIMUS CALCIUM
Randomised placebo controlled clinical trial of efficacy of MYOcardial protection in postacute inFLAMmatory cardiac involvEment due to COVID… Ended

2024-516463-84-00 Phase III 2 countries LOSARTAN POTASSIUM; PREDNISOLONE
Tiotropium in preventing preschool asthma (TIPP) Ended

2024-513916-84-00 Phase III 1 country TIOTROPIUM BROMIDE MONOHYDRATE

Showing 1–14 of 14 trials

← All sponsors A–Z